home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

The Global Public Health implications of Tropical Diseases Research

 
  February 05, 2009  
     
 
BioPark Hertfordshire, Welwyn Garden City
22nd May 2009


9:00 – 9:45            Registration

 

9:45 – 10:00         Introduction by the Chair:  Professor P.K. Das, University of Amsterdam, The Netherlands


10:00 – 10:45        
Diagnostics of Leprosy 

Dr. Annemieke Geluk, Leiden University Medical Center, The Netherlands

Preclinical M. leprae infection is a major source for leprosy transmission. Therefore, early detection of individual infected with M. leprae is crucial. However, to date there are no tests available that can identify preclinical leprosy.  HLA based bio-informatic tools combined with comparative genomics recently allowed us to identify M. leprae unique antigens. Evaluation of IFN-γ responses to these antigens in endemic areas revealed antigens that are only recognized in M. leprae infected/exposed individuals.  Use of such antigens in user-friendly LF assays asalternatives to ELISA-based assays to detect IFN-γ in response to M. leprae-specific antigens will contribute to prevention of leprosy-induced disabilities further transmission by otherwise undiagnosed and untreated index cases. 

 

10:45 – 11:30       Correlates of protection in co-infections

                                Dr.  Roberto Nisini, Istituto Superiore di Sanità, Italy

 

11:30- 11:35         Speakers photo


11:35 – 12:00        Mid-morning break

 

12:00 – 12:45       Global Health in the Tropics. Barriers and perspectives

Prof Francesco Castelli, University of Brescia, Italy

                                In Developing Countries a severe burden of infectious diseases caused by an array of different types of viruses, bacteria, worms and parasites is associated to poverty, malnutrition, scarce hygiene and dirty drinkable waters. These diseases share population targets, ecological niches and wide distribution with HIV/AIDS, tuberculosis and malaria, with extremely high public health impact. Research investments on control, prevention and drugs for diseases that are confined to poor countries are poor, even if increasing in the last decade. Strong political and scientific commitment is urgently needed to improve prevention, diagnosis and treatment of poverty-related diseases in Developing Countries

 

12:45– 12:55        Introduction to the Biopark        

12:55 – 14:00       Lunch and Poster Viewing

14:00 – 14:45       Malaria vaccines
Dr. Alan Thomas ,  Biomedical Primate Research Centre Rijswijk, The Netherlands

Malaria vaccine development has reached an exciting juncture. Mosquirix, the most advanced candidate, targets a single molecule expressed in early developmental phases of the parasite. As Mosquirix enters advanced clinical trials it is timely to consider other vaccine approaches that are being considered, to set these within the context of a parasite genome of some 5000 genes and to consider the tools available to select between promising vaccine candidates and accelerate progress towards the clinic.

14:45- 15:15         Schistosomiasis: what’s being done to control it

                                Mike Doenhoff

 

15:15 – 15:45       Afternoon Tea/Coffee and Last Poster Viewing

15:45 – 16:15       MHC/NK interactions and disease

Professor. John Trowsdale, Cambridge University, UK

 

16:15 – 16:45       Differential Th responses and the implications for HIV-1 infection

                                Dr William A Paxton, University of Amsterdam¸The Netherlands

                                HIV-1 infection undoubtedly occurs in combination with other Diseases and since a large number of people living with HIV-1 reside  in sub-Saharan Africa these will likely be TB as well as an array of parasitic pathogens, including Malaria or helminthes. How the HIV-1 develops in such individuals is still poorly understood but some in vitro data indicates that the Th stimulation profile can determine HIV-1  replication suggesting that differential immune responses May impact on  the HIV-1 disease course. We are currently studying the in vitro CD4  environment and how this can influence HIV-1 replication as well assaying the stimulatory response in HIV-1
and TB co-infected individuals. Understanding better which Th responses are preferentially infected with HIV-1 may provide insight into what responses should or should not be stimulated in a successful HIV-1 vaccine.

16:30 – 17:00      Chairman’s summing up.

18:00                      Soiree at *The Best Western Homestead Court Hotel for all the participants

 
 
Organized by: EuroSciCon
Invited Speakers: *
 
Deadline for Abstracts: see event website for details
 
Registration: http://www.regonline.co.uk/tropical09 
E-mail: enquiries@euroscicon.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.